The problem
Patient non-adherence is driving clinical trial failure.
The average failure rate of clinical trials attempting to progress from Phase 1 to Phase 3 approval.
The increased size of clinical trial panels that sponsors must fund to mitigate the effects of patient non-adherence.
The average number of clinical trials that fail due to patient non-adherence.
The average extension in trial duration that sponsors must fund to address the challenges of patient non-adherence.
